Eribulin mesilate versus vinorelbine in women with locally recurrent or metastatic breast cancer: A randomised clinical trial

Title
Eribulin mesilate versus vinorelbine in women with locally recurrent or metastatic breast cancer: A randomised clinical trial
Authors
Keywords
Progression-free survival, Tolerability, Locally recurrent or metastatic breast cancer, Eribulin
Journal
EUROPEAN JOURNAL OF CANCER
Volume 112, Issue -, Pages 57-65
Publisher
Elsevier BV
Online
2019-03-29
DOI
10.1016/j.ejca.2019.02.002

Ask authors/readers for more resources

Reprint

Contact the author

Publish scientific posters with Peeref

Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.

Learn More

Create your own webinar

Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.

Create Now